Distinguishing between exploratory and confirmatory preclinical research will improve translation.

Preclinical researchers confront two overarching agendas related to drug development: selecting interventions amid a vast field of candidates, and producing rigorous evidence of clinical promise for a small number of interventions. We suggest that each challenge is best met by two different, complem...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jonathan Kimmelman, Jeffrey S Mogil, Ulrich Dirnagl
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2014
Materias:
Acceso en línea:https://doaj.org/article/835d26b2650a48708202d848d2b3fd7d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:835d26b2650a48708202d848d2b3fd7d
record_format dspace
spelling oai:doaj.org-article:835d26b2650a48708202d848d2b3fd7d2021-11-11T05:37:10ZDistinguishing between exploratory and confirmatory preclinical research will improve translation.1544-91731545-788510.1371/journal.pbio.1001863https://doaj.org/article/835d26b2650a48708202d848d2b3fd7d2014-05-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24844265/?tool=EBIhttps://doaj.org/toc/1544-9173https://doaj.org/toc/1545-7885Preclinical researchers confront two overarching agendas related to drug development: selecting interventions amid a vast field of candidates, and producing rigorous evidence of clinical promise for a small number of interventions. We suggest that each challenge is best met by two different, complementary modes of investigation. In the first (exploratory investigation), researchers should aim at generating robust pathophysiological theories of disease. In the second (confirmatory investigation), researchers should aim at demonstrating strong and reproducible treatment effects in relevant animal models. Each mode entails different study designs, confronts different validity threats, and supports different kinds of inferences. Research policies should seek to disentangle the two modes and leverage their complementarity. In particular, policies should discourage the common use of exploratory studies to support confirmatory inferences, promote a greater volume of confirmatory investigation, and customize design and reporting guidelines for each mode.Jonathan KimmelmanJeffrey S MogilUlrich DirnaglPublic Library of Science (PLoS)articleBiology (General)QH301-705.5ENPLoS Biology, Vol 12, Iss 5, p e1001863 (2014)
institution DOAJ
collection DOAJ
language EN
topic Biology (General)
QH301-705.5
spellingShingle Biology (General)
QH301-705.5
Jonathan Kimmelman
Jeffrey S Mogil
Ulrich Dirnagl
Distinguishing between exploratory and confirmatory preclinical research will improve translation.
description Preclinical researchers confront two overarching agendas related to drug development: selecting interventions amid a vast field of candidates, and producing rigorous evidence of clinical promise for a small number of interventions. We suggest that each challenge is best met by two different, complementary modes of investigation. In the first (exploratory investigation), researchers should aim at generating robust pathophysiological theories of disease. In the second (confirmatory investigation), researchers should aim at demonstrating strong and reproducible treatment effects in relevant animal models. Each mode entails different study designs, confronts different validity threats, and supports different kinds of inferences. Research policies should seek to disentangle the two modes and leverage their complementarity. In particular, policies should discourage the common use of exploratory studies to support confirmatory inferences, promote a greater volume of confirmatory investigation, and customize design and reporting guidelines for each mode.
format article
author Jonathan Kimmelman
Jeffrey S Mogil
Ulrich Dirnagl
author_facet Jonathan Kimmelman
Jeffrey S Mogil
Ulrich Dirnagl
author_sort Jonathan Kimmelman
title Distinguishing between exploratory and confirmatory preclinical research will improve translation.
title_short Distinguishing between exploratory and confirmatory preclinical research will improve translation.
title_full Distinguishing between exploratory and confirmatory preclinical research will improve translation.
title_fullStr Distinguishing between exploratory and confirmatory preclinical research will improve translation.
title_full_unstemmed Distinguishing between exploratory and confirmatory preclinical research will improve translation.
title_sort distinguishing between exploratory and confirmatory preclinical research will improve translation.
publisher Public Library of Science (PLoS)
publishDate 2014
url https://doaj.org/article/835d26b2650a48708202d848d2b3fd7d
work_keys_str_mv AT jonathankimmelman distinguishingbetweenexploratoryandconfirmatorypreclinicalresearchwillimprovetranslation
AT jeffreysmogil distinguishingbetweenexploratoryandconfirmatorypreclinicalresearchwillimprovetranslation
AT ulrichdirnagl distinguishingbetweenexploratoryandconfirmatorypreclinicalresearchwillimprovetranslation
_version_ 1718439509429846016